ARMISTICE CAPITAL
Armistice Capital is a global, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sector.
ARMISTICE CAPITAL
Founded:
2012-01-01
Status:
Active
Contact:
(212) 231-4930
Technology used in webpage:
IPhone / Mobile Compatible U.S. Server Location Smart App Banner
Similar Organizations
AlphaCoin Fund
AlphaCoin Fund is a venture capital fund focused on blockchain startups and crypo-asset investments.
NIO Capital
NIO Capital is a fund manager investing in themes reshaping the automotive, new energy and technology sectors.
Current Employees Featured
Steven Boyd Founder & Managing Partner @ Armistice Capital
Founder & Managing Partner
2012-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-26 | ProMIS Neurosciences | Armistice Capital investment in Post-IPO Equity - ProMIS Neurosciences | 122.7 M USD |
| 2024-06-17 | Assembly Biosciences | Armistice Capital investment in Post-IPO Equity - Assembly Biosciences | 12.6 M USD |
| 2024-05-02 | Corvus Pharmaceuticals | Armistice Capital investment in Post-IPO Equity - Corvus Pharmaceuticals | 30.6 M USD |
| 2024-04-18 | Zura Bio | Armistice Capital investment in Post-IPO Equity - Zura Bio | 112.5 M USD |
| 2024-04-05 | Protara Therapeutics | Armistice Capital investment in Post-IPO Equity - Protara Therapeutics | 45 M USD |
| 2024-03-28 | CervoMed | Armistice Capital investment in Post-IPO Debt - CervoMed | 149.4 M USD |
| 2024-02-12 | Greenidge | Armistice Capital investment in Post-IPO Equity - Greenidge | 6 M USD |
| 2024-02-08 | Tenaya Therapeutics | Armistice Capital investment in Post-IPO Equity - Tenaya Therapeutics | 50 M USD |
| 2024-01-23 | Outlook Therapeutics | Armistice Capital investment in Post-IPO Equity - Outlook Therapeutics | 65 M USD |
| 2023-10-23 | Aligos Therapeutics | Armistice Capital investment in Post-IPO Equity - Aligos Therapeutics | 92 M USD |
More informations about "Armistice Capital"
Armistice Capital
Armistice Capital is a global, long/short, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sectors. Disclaimer; About; Contact; INVESTOR …See details»
Armistice Capital - Crunchbase Investor Profile
Armistice Capital focuses on post-IPO equity and debt investments in biotechnology, healthcare, and pharmaceutical industries, primarily in New York, San Diego, and San Francisco, United States. Learn More. Similar …See details»
SEC FORM D/A - SEC.gov
Armistice Capital Offshore Fund Ltd. Street Address 1 Street Address 2; WAYSTONE CORPORATE SERVICES (CAYMAN) LTD: SUITE 5B201, 2ND FLOOR, ONE NEXUS WAY: …See details»
Armistice Capital - Company Database - Wall Street Oasis
Steven Boyd, Chief Investment Officer, founded Armistice Capital in 2012. Steven was the first analyst at Senator Investment Group in 2008, joining the firm with its founders from York …See details»
Armistice Capital - Investments, Portfolio & Company Exits
Armistice Capital 's most notable exits include 2seventy bio, Tenaya Therapeutics, and Aligos Therapeutics. Which industries has this organization had the most exits in? Show . 2seventy …See details»
ARMISTICE CAPITAL, Current Portfolio, 13F Holdings (2025-02-16)
Feb 16, 2025 ARMISTICE CAPITAL, LLC 13F. ARMISTICE CAPITAL, LLC Last update 2025-02-16 231 Stocks (63 new) Value $7.33 Bil Turnover 17 % Countries: Top Holdings: …See details»
ARMISTICE CAPITAL, LLC Schedule 13G/A Filing
Dec 31, 2024 ARMISTICE CAPITAL, LLC Total Shares: 2.51m. Subject Company: ProMIS Neurosciences Inc View Complete Ownership History. Backtest Filed as of Date: 2025-02-14: …See details»
About – Armistice Capital - Medium
Long/short, value-oriented, event-driven, New York-based global hedge fund Armistice Capital was launched in 2012 by founder Steven Boyd. Primarily investing in the consumer and …See details»
Armistice Capital – Fund and Executive Details - Private Fund Data
Armistice Capital is a hedge fund company based in New York, NY. They operate 1 private fund and have approximately $506 million in total assets under management (AUM). You can view …See details»
Armistice Capital - Funding, Financials, Valuation & Investors
Jul 17, 2012 Armistice Capital has raised a single venture fund, Armistice Capital Fund. This fund was announced on Jul 17, 2012 and raised a total of . obfuscated. obfuscated. …See details»
ARMISTICE CAPITAL, LLC Schedule 13G/A Filing
Feb 14, 2025 ARMISTICE CAPITAL, LLC Total Shares: 1.03m. Subject Company: Aptose Biosciences Inc View Complete Ownership History. Backtest Filed as of Date: 2025-02-14: …See details»
Exclusive | This Hedge Fund Delivered a Solid Year. So Why Can’t …
Armistice Capital delivered the goods to investors for over a dozen years. The hedge fund outperformed rivals in 2024, and its record since inception trounces the broader stock market.See details»
SC 13G - SEC.gov
The percentage of Shares reported to be beneficially owned by the Reporting Persons are based on 69,366,486 Shares outstanding as of December 7, 2021, as reported in the Issuer’s …See details»
Armistice Capital Increases Position in Cyclo Therapeutics (CYTH)
Fintel reports that Armistice Capital has filed a 13G form with the SEC disclosing ownership of 1.03MM shares of Cyclo Therapeutics Inc ().This represents 10.8% of the company. In their …See details»
HUB Capital Inc. - Canadian Investment Regulatory Organization
You can find the Canadian Investment Regulatory Organization (CIRO) at CIRO.ca with our fresh look and feel. The following sections of the legacy mfda.ca and iiroc.ca sites have been …See details»
Armistice Capital - Contacts, Employees, Board Members
Armistice Capital has 1 current employee profile, Founder & Managing Partner Steven Boyd. Contacts. Edit Contacts Section. Job Department. Protected Content. Director of Operations. …See details»
Aligned Capital Partners Inc. | christiansonfinancial.ca
Aligned Capital Partners Inc. (ACPI), a pioneer in the investment dealer community in Canada, has been providing independent investment advice to retail investors since 1987. In 2012, …See details»
Gumax | Non-Profit Organization In Woodbridge
Gumax is a dedicated non-profit organization in Woodbridge, committed to uplifting our community through various impactful initiatives and programs. Skip to content. f; t; g; i; y; 609 …See details»
Space Force Organization - United States Space Force
The Chief of Space Operations (CSO) serves as the senior uniformed Space Force officer responsible for the organization, training and equipping of all organic and assigned space …See details»
ARMISTICE CAPITAL, LLC Schedule 13G/A Filing
Dec 31, 2024 ARMISTICE CAPITAL, LLC Total Shares: 179k. Subject Company: Momentus Inc View Complete Ownership History. Backtest Filed as of Date: 2025-02-14: Event Date: 2024 …See details»